Correlation of the changes of serum alpha2-Heremans-Schmid glycoprotein levels with metabolic syndrome

doi:10.3969/j.issn.1673-8640.2017.08.004

Abstract

Abstract:

Objective To investigate the correlation of the changes of serum alpha2-Heremans-Schmid glycoprotein（AHSG）levels with metabolic syndrome（MS）. Methods A total of 726 subjects were enrolled. Their clinical data [waist circumference, blood pressure,body mass index（BMI）, fasting plasma glucose（FPG）, total cholesterol （TC）, triglyceride（TG）,high-density lipoprotein cholesterol（HDL-C）,low-density lipoprotein cholesterol（LDL-C）,C-reactive protein（CRP）,homeostasis model assessment for insulin resistance（HOMA-IR）and free fatty acid（FFA）] were collected,and serum levels of AHSG were determined by enzyme-linked immunosorbent assay. A total of 211 of 726 subjects were identified with MS,according to the revision of the Adult Treatment Panel Ⅲ of the National Cholesterol Education Program（NCEP-ATP Ⅲ）in 2005. The parameters were compared between MS and non-MS groups. The relation between AHSG and parameters was analyzed by Pearson correlation analysis and multiple linear regression analysis. The quartiles of AHSG and the relative risk of MS were evaluated by Logistic regression analysis,and receiver operating characteristic（ROC）curve was used to assess the role of AHSG for the diagnosis of MS. Results Serum AHSG level was higher in MS group than that in non-MS group（P<0.05）,and there was statistical significance for the other parameters between the 2 groups（P<0.05,P<0.01）. AHSG was positively correlated with waist circumference,FPG,TG,LDL-C,CRP,HOMA-IR and FFA（r=0.094,0.133,0.107,0.078,0.088,0.126 and 0.119,P<0.05）,and was correlated independently with waist circumference, CRP and HOMA-IR（β=0.088, 0.083 and 0.091, P=0.022, 0.033 and 0.014）. The risk of MS increased with increasing quartiles of AHSG in Logistic regression analysis（P<0.01）. ROC curve showed that the area under the curve was 0.709,and the cut-off value was 285.3 μg/mL. The sensitivity was 70.5%,and the specificity was 73.8%. Conclusions Increased AHSG level is one of risk factors for MS,and it plays a role for predicting the incidence of MS.

Key words: Alpha2-Heremans-Schmid glycoprotein, Metabolic syndrome, Correlation

CLC Number:

R446.1

JI Hongbing, JU Huixiang, SUN Mingzhong, CHEN Hongmei, HAN Yuqing, ZHOU Zhongwei. Correlation of the changes of serum alpha2-Heremans-Schmid glycoprotein levels with metabolic syndrome[J]. Laboratory Medicine, 2017, 32(8): 677-680.

Figures/Tables 5

References 11

[1]	NIKOLOPOULOU A,KADOGLOU N P.Obesity and metabolic syndrome as related to cardiovascular disease[J]. Expert Rev Cardiovasc Ther,2012,10(7):933-939.
[2]	MORI K,EMOTO M,INABA M.Fetuin-A:a multifunctional protein[J]. Recent Pat Endocr Metab Immune Drug Discov,2011,5(2):124-146.
[3]	周中卫,孙明忠,居会祥,等. 糖尿病视网膜病变患者血清胎球蛋白A水平的变化及其与CRP的相关性[J]. 检验医学,2014,29(10):1034-1036.
[4]	周中卫,居会祥,孙明忠,等. 单纯性超重和肥胖人群血清胎球蛋白A水平的变化[J]. 中华内分泌代谢杂志,2016,32(1):42-46.
[5]	NOURELDEIN M H,ABD EL-RAZEK R S,EL-HEFNAWY M H,et al. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis[J]. Diabetes Res Clin Pract,2015,109(3):513-520.
[6]	王敬瀚,苏丽,王中心,等. 腰围是代谢综合征最主要的危险成分[J]. 中华高血压杂志,2007,15(11):896-899.
[7]	高孟,傅世英,李莹,等. 正常体重指数成年人中心性肥胖对代谢综合征其他组分聚集性的影响[J]. 中华流行病学杂志,2012,33(5):460-463.
[8]	TURCHIANO M,SWEAT V,FIERMAN A,et al.Obesity,metabolic syndrome,and insulin resistance in urban high school students of minority race/ethnicity[J]. Arch Pediatr Adolesc Med,2012,166(11):1030-1036.
[9]	李绍臣,王建文,郭琳娜. 炎症相关因子在代谢综合征形成中的作用研究[J]. 陕西医学杂志,2016,45(5):560-562.
[10]	BENNETT N R,FERGUSON T S,BENNETT F I,et al.High-sensitivity C-reactive protein is related to central obesity and the number of metabolic syndrome components in Jamaican young adults[J]. Front Cardiovasc Med,2014,1:12.
[11]	XU Y,XU M,BI Y,et al.Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese[J]. Atherosclerosis,2011,216(1):180-186.

组别	AHSG（μg/mL）	模型1	模型2	模型3
低四分位组	≤222.10	1	1	1
中四分位组	222.20~271.50	1.528（1.017~2.534）	1.344（1.010~1.828）	1.212（1.013~1.468）
高四分位组	271.60~318.60	2.142（1.294~3.515）	1.873（1.192~3.021）	1.557（1.189~2.214）
极高四分位组	≥318.70	3.353（1.473~5.254）	2.905（1.721~4.816）	2.613（1.510~4.122）
趋势P值		<0.01	<0.01	<0.01

组别	AHSG（μg/mL）	模型1	模型2	模型3
低四分位组	≤222.10	1	1	1
中四分位组	222.20~271.50	1.528（1.017~2.534）	1.344（1.010~1.828）	1.212（1.013~1.468）
高四分位组	271.60~318.60	2.142（1.294~3.515）	1.873（1.192~3.021）	1.557（1.189~2.214）
极高四分位组	≥318.70	3.353（1.473~5.254）	2.905（1.721~4.816）	2.613（1.510~4.122）
趋势P值		<0.01	<0.01	<0.01

[1]	WANG Yang, MO Huifang, SHEN Ruojian, SHEN Yifeng, WANG Beili, PAN Baishen, GUO Wei. Analysis on the difference of lipoprotein（a） particle concentration and mass concentration in certain disease states [J]. Laboratory Medicine, 2023, 38(5): 405-412.
[2]	ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418.
[3]	KE Qiulei, HUANG Jing, CHEN Aizheng, SONG Yanfeng, SU Xiaofeng. Subgingival flora and the relations between periodontal health indexes and risk of periodontal disease in patients with GDM [J]. Laboratory Medicine, 2023, 38(2): 163-166.
[4]	CHEN Xuewei, LI Yirong. Candidate biomarkers in metabolic syndrome based on GEO database [J]. Laboratory Medicine, 2023, 38(1): 32-38.
[5]	YANG Xiaolan, HU Zengjun, WANG Shengqing, MA Shuxia, ZENG Yongjie, WANG Chenglei. Distribution of some common intestinal bacteria in elderly patients with acute cerebral infarction and its correlation with cognitive function [J]. Laboratory Medicine, 2022, 37(9): 839-843.
[6]	JU Yinghui, MO Huifang, WU Hui, CHEN Pu, GUO Wei, WANG Beili. Performance comparison of lymphocyte subset determination by 6-color flow cytometry with 2 different reagents [J]. Laboratory Medicine, 2022, 37(3): 270-273.
[7]	CHEN Qiuying, ZHONG Yinghua, ZHAO Nan, YIN Haibo, XU Yang, SHU Ming. High prolactin caused by risperidone related factors [J]. Laboratory Medicine, 2022, 37(2): 122-125.
[8]	CHEN Liang, LI Lin, LI Xia, ZHANG Yan, WU Jiongrui, GAO Yiming. Correlation between metabolic syndrome and moderate-to-severe periodontitis complicated with psoriasis [J]. Laboratory Medicine, 2022, 37(2): 126-129.
[9]	CHI Wenjing, DING Li, LIU Yixin, YANG Feng, LIU Tao, CONG Jianhua, GAO Zhenhui, ZHAO Hu, ZHANG Yanmei. Correlation analysis of Helicobacter pylori colonization level and metabolic syndrome in physical examination population in Shanghai [J]. Laboratory Medicine, 2022, 37(11): 1034-1038.
[10]	ZHOU Zhongwei, JU Huixiang, JIN Hao, CHEN Hongmei, SUN Mingzhong. Relationship between alpha 2-Heremans-Schmid glycoprotein to adiponectin ratio and type 2 diabetes mellitus complicated with metabolic syndrome [J]. Laboratory Medicine, 2020, 35(5): 414-419.
[11]	LIU Xiaoni, WANG Ying, LI Taotao, MA Xiaomin, ZHAO Huanlao. Correlation of insulin resistance index and chronic inflammation index in type 2 diabetes mellitus patients with metabolic syndrome [J]. Laboratory Medicine, 2019, 34(9): 826-830.
[12]	WANG Yue, QU Chenxue, GONG Yan, GAO Xueshuo, WANG Guohong, XU Guobin. Comparison of the results' consistency of 3 automated coagulation analyzers for coagulation items [J]. Laboratory Medicine, 2019, 34(3): 253-258.
[13]	GONG Jian, LIU Fang, GAO Peng, XU Jianfeng. Changes of clinical laboratory determination indicators in male androgenic alopecia patients [J]. Laboratory Medicine, 2018, 33(8): 674-678.
[14]	YANG Feng, ZHANG Jinghao, FANG Yi, GUO Mingquan, LIU Yue, ZHAO Hu, ZHANG Yanmei. Relationship of routine examinations and treatment with the etiological diagnosis of acute infectious diarrhea [J]. Laboratory Medicine, 2018, 33(5): 379-383.
[15]	ZHU Wenkui, XU Qi, CHEN Jin. Correlations of serum calcium and free fatty acid with metabolic syndrome among elders in community [J]. Laboratory Medicine, 2018, 33(5): 407-410.